Amy Ku

Also affiliated with Columbia University Irving Medical Center, China Medical University Hospital

MedicineImmunology and MicrobiologyEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer”.

Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer

Cancer Prevention Research(2021)10.1158/1940-6207.capr-21-0031

N/A

0.693DataRank · unranked

14 citations

Wen Bu, Weiyu Jiang, Amy Ku, Jyoti Kapali, Sagar Dhamne +5 more

Analysis of respiratory and systemic immune responses in COVID-19 reveals mechanisms of disease pathogenesis

medRxiv(2020)10.1101/2020.10.15.20208041

N/A

0.489DataRank · unranked

25 citations

Pranay Dogra, Joshua I. Gray, Steven B. Wells, Thomas J. Connors, Stuart P. Weisberg +18 more

Immune and epithelial determinants of age-related risk and alveolar injury in fatal COVID-19

JCI Insight(2022)10.1172/jci.insight.157608

N/A

0.345DataRank · unranked

9 citations

Mine Yilmaz, Shanila Shakil, Amy Ku, Pranay Dogra, Thomas J. Connors +13 more

Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy

Frontiers in Immunology(2024)10.3389/fimmu.2024.1258369

N/A

0.269DataRank · unranked

5 citations

Stephanie N. Johnson, Camillo Bechi Genzano, Martin A. Leon, Amy Ku, Fernando A. González +5 more

Considerations for enhancing dupilumab research in hypereosinophilic syndromes

The Journal of Allergy and Clinical Immunology In Practice(2025)10.1016/j.jaip.2025.03.028

N/A

0DataRank · unranked

2 citations

Wen-Chun Lo, Szu-Yu Huang, Su‐Boon Yong, Chin-Yuan Yii, Amy Ku

Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma

Drug Resistance Updates(2025)10.1016/j.drup.2025.101312

N/A

0DataRank · unranked

0 citations

Luigi Scotto, Agnès Basseville, Thomas Litman, Haoran Xue, Lubov Petrukhin +14 more